Total Payments
$7,137
2024 Payments
$1,979
Companies
61
Transactions
353
Medicare Patients
11,483
Medicare Billing
$4.2M
Payment Breakdown by Category
Food & Beverage$5,849 (81.9%)
Other$681.53 (9.5%)
Education$606.93 (8.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,849 | 326 | 81.9% |
| Long term medical supply or device loan | $681.53 | 7 | 9.5% |
| Education | $606.93 | 20 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,163 | 38 | $0 (2024) |
| PFIZER INC. | $629.87 | 55 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $438.66 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $320.50 | 14 | $0 (2024) |
| Sirtex Medical Inc | $295.82 | 5 | $0 (2024) |
| Genentech USA, Inc. | $275.85 | 16 | $0 (2020) |
| Merck Sharp & Dohme LLC | $247.81 | 15 | $0 (2023) |
| Janssen Biotech, Inc. | $247.51 | 12 | $0 (2024) |
| Incyte Corporation | $224.98 | 7 | $0 (2024) |
| Medtronic, Inc. | $221.36 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,979 | 64 | Novartis Pharmaceuticals Corporation ($743.83) |
| 2023 | $1,371 | 63 | Novartis Pharmaceuticals Corporation ($129.93) |
| 2022 | $485.34 | 25 | Medtronic, Inc. ($91.05) |
| 2021 | $164.11 | 6 | Lilly USA, LLC ($100.39) |
| 2020 | $269.44 | 14 | Genentech USA, Inc. ($58.27) |
| 2019 | $615.89 | 36 | Novartis Pharmaceuticals Corporation ($86.75) |
| 2018 | $869.44 | 75 | PFIZER INC. ($142.41) |
| 2017 | $1,383 | 70 | Sirtex Medical Inc ($240.90) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.41 | General |
| 12/04/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Oncology | ||||||
| 11/18/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Genetic Disease | ||||||
| 11/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: Hematology/Oncology | ||||||
| 11/01/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: HEMATOLOGY | ||||||
| 10/31/2024 | Inari Medical, Inc. | CT THROMBECTOMY SYSTEM KIT (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: VTE | ||||||
| 10/23/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Oncology | ||||||
| 10/16/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Medtronic, Inc. | OSTEOCOOL RF ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.34 | General |
| 09/19/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: Hematology | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Monoclonal Antibody | ||||||
| 07/22/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Oncology | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 07/15/2024 | PFIZER INC. | INLYTA (Drug), IBRANCE, TALZENNA | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 2,869 | 94,092 | $5.4M | $1.1M |
| 2022 | 52 | 2,324 | 90,530 | $5.4M | $833,906 |
| 2021 | 51 | 3,166 | 122,423 | $6.4M | $1.1M |
| 2020 | 50 | 3,124 | 127,121 | $6.4M | $1.1M |
Total Patients
11,483
Total Services
434,166
Medicare Billing
$4.2M
Procedure Codes
203
All Medicare Procedures & Services
203 procedure records from CMS Medicare Utilization — Page 3 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2022 | 28 | 8,170 | $1.8M | $270,254 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 284 | 1,914 | $704,352 | $177,342 | 25.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 76 | 975 | $689,325 | $101,797 | 14.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 1,680 | $99,180 | $28,702 | 28.9% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 53 | 158 | $25,520 | $25,219 | 98.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 117 | 439 | $108,433 | $23,755 | 21.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 79 | 450 | $140,850 | $22,680 | 16.1% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 79 | 1,708 | $184,464 | $20,813 | 11.3% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 17 | 18 | $86,436 | $20,591 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 244 | $61,000 | $15,529 | 25.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 315 | 1,816 | $65,376 | $13,914 | 21.3% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2022 | 11 | 97 | $48,500 | $12,051 | 24.8% |
| 96409 | Administration of chemotherapy into vein using push technique | Office | 2022 | 17 | 133 | $66,500 | $10,580 | 15.9% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2022 | 22 | 182 | $62,608 | $9,284 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $37,290 | $7,662 | 20.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 52 | 330 | $51,810 | $7,648 | 14.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 49 | $34,006 | $7,303 | 21.5% |
| J1750 | Injection, iron dextran, 50 mg | Office | 2022 | 13 | 534 | $21,360 | $6,506 | 30.5% |
| 85055 | Reticulated (young) platelet measurement | Office | 2022 | 41 | 135 | $19,305 | $4,750 | 24.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 41 | $19,270 | $4,195 | 21.8% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2022 | 27 | 24,900 | $49,800 | $4,063 | 8.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 33 | 143 | $23,023 | $3,196 | 13.9% |
| 99195 | Drawing of blood for a medical problem | Office | 2022 | 12 | 46 | $12,064 | $3,178 | 26.3% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2022 | 11 | 63 | $18,207 | $2,779 | 15.3% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 25 | 151 | $15,100 | $2,378 | 15.8% |
About Dr. Akbar Rizvi, MD
Dr. Akbar Rizvi, MD is a Hematology & Oncology healthcare provider based in Mckinney, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225023948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Akbar Rizvi, MD has received a total of $7,137 in payments from pharmaceutical and medical device companies, with $1,979 received in 2024. These payments were reported across 353 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($5,849).
As a Medicare-enrolled provider, Rizvi has provided services to 11,483 Medicare beneficiaries, totaling 434,166 services with total Medicare billing of $4.2M. Data is available for 4 years (2020–2023), covering 203 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Mckinney, TX
- Active Since 09/19/2005
- Last Updated 02/04/2015
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1225023948
Products in Payments
- KISQALI (Drug) $753.26
- SIR-Spheres Microspheres (Device) $295.82
- OPDIVO (Biological) $276.47
- KEYTRUDA (Biological) $214.37
- Optune (Device) $201.34
- OSTEOCOOL RF ABLATION SYSTEM (Device) $198.91
- SARCLISA (Biological) $167.51
- BOSULIF (Drug) $158.59
- IBRANCE (Drug) $148.80
- DARZALEX (Biological) $142.87
- IMFINZI (Biological) $137.51
- BESREMI (Drug) $110.77
- ZYTIGA (Drug) $110.65
- XARELTO (Drug) $110.07
- Avastin (Biological) $106.25
- XALKORI (Drug) $105.99
- AFINITOR (Drug) $100.96
- JAKAFI (Drug) $99.57
- LYNPARZA (Drug) $92.81
- ELIQUIS (Drug) $88.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Mckinney
Dr. Sultan Chowdhary, Md, MD
Hematology & Oncology — Payments: $13,456
Hematology & Oncology $13,456
Dr. Nithya Palanisamy, Md, MD
Hematology & Oncology — Payments: $9,411
Hematology & Oncology $9,411
Amanullah Khan, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $3,366
Hematology & Oncology $3,366
Dr. Arisha Patel, Md, Mba, MD, MBA
Hematology & Oncology — Payments: $112.89
Hematology & Oncology $112.89